OP0068 A Phase 3 Randomised Controlled Trial to Compare CT-P13 with Infliximab in Patients with Active Rheumatoid Arthritis: 54 Week Results from the Planetra Study

Controlled Trial ◽

Phase 3 ◽

059 A phase 3, randomised controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naïve patients with active rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/kez106.058 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Cited By ~ 11

Author(s):

R van Vollenhoven ◽

T Takeuchi ◽

A L Pangan ◽

A Friedman ◽

M F Mohamed ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Trial ◽

Phase 3 ◽

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

Annals of the Rheumatic Diseases ◽

10.1136/ard.2008.101659 ◽

2008 ◽

Vol 68 (6) ◽

pp. 797-804 ◽

Cited By ~ 308

Author(s):

J Smolen ◽

R B Landewe ◽

P Mease ◽

J Brzezicki ◽

D Mason ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Trial ◽

Certolizumab Pegol ◽

Efficacy And Safety ◽

Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-203480 ◽

2013 ◽

Vol 73 (8) ◽

pp. 1508-1514 ◽

Cited By ~ 50

Author(s):

Xavier Mariette ◽

Stephanie Rouanet ◽

Jean Sibilia ◽

Bernard Combe ◽

Xavier Le Loët ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Low Dose ◽

Controlled Trial ◽

Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial

Arthritis Research & Therapy ◽

10.1186/s13075-015-0612-7 ◽

2015 ◽

Vol 17 (1) ◽

Cited By ~ 31

Author(s):

Joel M Kremer ◽

Alan J Kivitz ◽

Jesus A Simon-Campos ◽

Evgeny L Nasonov ◽

Hans-Peter Tony ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Glomerular Filtration Rate ◽

Glomerular Filtration ◽

Filtration Rate ◽

Controlled Trial ◽

Measured Glomerular Filtration Rate ◽

Faculty Opinions recommendation of MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158507.618812 ◽

2009 ◽

Author(s):

Jacques Morel

Keyword(s):

Rheumatoid Arthritis ◽

Early Rheumatoid Arthritis ◽

Radiographic Progression ◽

Controlled Trial ◽

Randomised Controlled ◽

Bone Oedema

Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166102.628092 ◽

2009 ◽

Author(s):

Jim Orr ◽

Fadi Abu Shahin

Keyword(s):

Ovarian Cancer ◽

Controlled Trial ◽

Advanced Ovarian Cancer ◽

Open Label ◽

Phase 3 ◽

Dose Dense ◽

Faculty Opinions recommendation of Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13827960.15267062 ◽

2012 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Gastric Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

D2 Gastrectomy ◽

Faculty Opinions recommendation of Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718302523.793494710 ◽

2014 ◽

Author(s):

Anthony Harries

Keyword(s):

Clinical Outcomes ◽

Antiretroviral Treatment ◽

Controlled Trial ◽

Phase 3 ◽

Delayed Initiation ◽

Randomised Controlled ◽

Hiv 1

Faculty Opinions recommendation of Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9952956.10680055 ◽

2011 ◽

Author(s):

Jacques Bernier

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Controlled Trial ◽

Phase 3 ◽

Conventional Radiotherapy ◽

Intensity Modulated ◽

Parotid Sparing ◽

Upfront FOLFOXIRI Plus Bevacizumab and Reintroduction after Progression versus mFOLFOX6 Plus Bevacizumab Followed by FOLFIRI Plus Bevacizumab in the Treatment of Patients with Metastatic Colorectal Cancer (TRIBE2): A Multicentre, Open-Label, Phase 3, Randomised Controlled Trial by GONO

SSRN Electronic Journal ◽

10.2139/ssrn.3478102 ◽

2019 ◽

Author(s):

Chiara Cremolini ◽

Carlotta Antoniotti ◽

Daniele Rossini ◽

Sara Lonardi ◽

Fotios Loupakis ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽